The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers
Open accessAbstract
We describe a Massachusetts Bureau of Substance Abuse Services’ (BSAS) initiative to disseminate the office-based opioid treatment with buprenorphine (OBOT-B) Massachusetts Model from its development at Boston Medical Center (BMC) to its implementation at fourteen community health centers (CHCs) beginning in 2007. The Massachusetts Collaborative Care Model for the delivery of opioid agonist therapy with buprenorphine, in which nurses working with physicians play a central role in the evaluation and monitoring of patients, holds promise for the effective expansion of treatment for opioid use disorders. The training of and technical assistance for the OBOT nurses as well as a limited program assessment are described. Data spanning 6 years (2007 – 2013) reports patient demographics, prior treatment for opioid use disorders, history of overdose, housing, and employment. The expansion of OBOT to the fourteen CHCs increased the number of physicians who were “waivered” (i.e., enabling their prescribing of buprenorphine) by 375%, from 24 to 114, within 3 years. During this period the annual admissions of OBOT patients to CHCs markedly increased. Dissemination of the Massachusetts Model of the Office-Based Opioid Treatment with Buprenorphine employing a collaborative care model with a central role for nursing enabled implementation of effective treatment for patients with an opioid use disorder at community health centers throughout Massachusetts while effectively engaging primary care physicians in this endeavor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improving chronic illness care: translating evidence into action
Wagner, E. H., Austin, B. T., Davis, C., Hindmarsh, M., Schaefer, J., & Bonomi, A. (2001) · Health Affairs · doi:10.1377/hlthaff.20.6.64 · Cited by 3,446
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622
Alford, D. P., LaBelle, C. T., Kretsch, N., Bergeron, A., Winter, M., Botticelli, M., & Samet, J. H. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.541 · Cited by 267
Self-citation
Research works printed but not linked: 8
- Alford, 2007, Treating homeless opioid dependent patients with buprenorphine in an office-based setting, Journal of General Internal Medicine, 22, 171, 10.1007/s11606-006-0023-1 · DOI
- Barry, 2009, Integrating buprenorphine treatment into office-based practice: A qualitative study, Journal of General Internal Medicine, 24, 218, 10.1007/s11606-008-0881-9 · DOI
- Haddad, 2013, Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes, Drug and Alcohol Dependence, 131, 127, 10.1016/j.drugalcdep.2012.12.008 · DOI
- Kissin, 2006, Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence, Journal of Addictive Diseases, 25, 91, 10.1300/J069v25n04_09 · DOI
- Knapp, 2012, Implementation science in the real world: A streamlined model, Journal for Healthcare Quality, 34, 27, 10.1111/j.1945-1474.2012.00220.x · doi:10.1111/j.1945-1474.2012.00220.x
- Turner, 2005, Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence, Archives of Internal Medicine, 165, 1769, 10.1001/archinte.165.15.1769 · DOI
- Walley, 2008, Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers, Journal of General Internal Medicine, 23, 1393, 10.1007/s11606-008-0686-x · DOI · Paper page
- Wesson, 2003, The clinical opiate withdrawal scale (COWS), Journal of Psychoactive Drugs, 35, 253, 10.1080/02791072.2003.10400007 · DOI · Paper page
Cited by
Volkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503
Management of opioid use disorder in the USA: present status and future directions
Blanco, C., & Volkow, N. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33078-2 · Cited by 407
Krawczyk, N., Rivera, B. D., Jent, V., Keyes, K. M., Jones, C. M., & Cerdá, M. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103786 · Cited by 308
“Models such as the Hub-and-Spoke, nurse care or collaborative care models may help to address these barriers and improve provision of MOUD (Brooklyn & Sigmon, 2017; LaBelle et al., 2016).”
Primary Care–Based Models for the Treatment of Opioid Use Disorder: A Scoping Review
Korthuis, P. T., McCarty, D., Weimer, M., Bougatsos, C., Blazina, I., Zakher, B., Grusing, S., Devine, B., & Chou, R. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2149 · Cited by 297
Hadland, S. E., Wharam, J. F., Schuster, M. A., Zhang, F., Samet, J. H., & Larochelle, M. R. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.0745 · Cited by 294
Self-citationReif, S., Brolin, M. F., Stewart, M. T., Fuchs, T. J., Speaker, E., & Mazel, S. B. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.07.007 · Cited by 58
Schuman-Olivier, Z., Borodovsky, J. T., Steinkamp, J., Munir, Q., Butler, K., Greene, M. A., Goldblatt, J., Xie, H. Y., & Marsch, L. A. (2018) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0122-4 · Cited by 44
Price, C. J., Merrill, J. O., McCarty, R. L., Pike, K. C., & Tsui, J. I. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.05.013 · Cited by 33
Bagley, S. M., Schoenberger, S. F., dellaBitta, V., Lunze, K., Barron, K., Hadland, S. E., & Park, T. W. (2023) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2022.08.026 · Cited by 33
Dissemination of Contingency Management for the Treatment of Opioid Use Disorder
DeFulio, A. (2023) · Perspectives on Behavior Science · doi:10.1007/s40614-022-00328-z · Cited by 28
“treatment has been a context for successful collaborative care (Alford et al., 2011; LaBelle et al., 2016).”
BackgroundWeinstein, Z. M., Gryczynski, G., Cheng, D. M., Quinn, E., Hui, D., Kim, H. W., Labelle, C., & Samet, J. H. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.05.010 · Cited by 23
Self-citationSchuman‐Olivier, Z., Fatkin, T., Creedon, T. B., Samawi, F., Moore, S. K., Okst, K., Fredericksen, A. (., Oxnard, A. (., Roll, D., Smith, L., et al. (2023) · The American Journal on Addictions · doi:10.1111/ajad.13364 · Cited by 15
Sokol, R., Albanese, M., Chew, A., Early, J., Grossman, E., Roll, D., Sawin, G., Wu, D. J., & Schuman-Olivier, Z. (2019) · Addiction Science & Clinical Practice · doi:10.1186/s13722-019-0176-y · Cited by 14
Implementing Group Visits for Opioid Use Disorder: A Case Series
Sokol, R., Albanese, M., Albanese, C., Coste, G., Grossman, E., Morrill, D., Roll, D., Sobieszczyk, A., & Schuman-Olivier, Z. (2020) · Substance Abuse · doi:10.1080/08897077.2019.1635958 · Cited by 12
“In this model, care begins with the centralized OBOT RNCMs.18 Patients are referred to these RNCMs from primary care providers within our system, from higher levels of care inside and outside of our system, such as inpatient Transitional Support Services and Clinical Stabilization Services (TSS/CSS; American Society o…”
MethodInfluential
Metadata
- Authors
- LaBelle, C. T., Han, S. C., Bergeron, A., & Samet, J. H.
- Venue
- Journal of Substance Abuse Treatment
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 60
- Pages
- 6-13
- ISSN
- 0740-5472 (ISSN-L)
- OpenAlex
- W789546000
- Cited by
- 228
- References
- 3
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Commonwealth of Massachusetts (0248908)
- NIDA (R25DA013582)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.